NCT01974635

Brief Summary

In this study, an FDA-cleared device and type of treatment called "AMES," which stands for Assisted Movement with Enhanced Sensation, will be used to determine whether sensation in the upper limb of individuals with incomplete spinal cord injuries, acquired brain injury, or stroke improves along with movement through treatment. We hypothesize that measureable improvement in the sensation of the upper limb will precede improvement in functional movement.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2013

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

October 21, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 1, 2013

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
4.2 years until next milestone

Results Posted

Study results publicly available

June 13, 2019

Completed
Last Updated

June 13, 2019

Status Verified

June 1, 2019

Enrollment Period

1.5 years

First QC Date

October 21, 2013

Results QC Date

March 29, 2019

Last Update Submit

June 11, 2019

Conditions

Keywords

Spinal Cord InjuryRobotic therapyRehabilitationSensationMovementProprioceptionStrokeAcquired Brain Injury

Outcome Measures

Primary Outcomes (1)

  • Joint Position Test - AMES Device

    Testing proprioceptive sensation, the subject, with eyes closed, attempts to identify verbally the direction of motion (i.e., flexion or extension) as the AMES device randomly moves the subject's thumb and fingers, or the whole hand, into flexion and extension.

    Immediately after each treatment on the AMES Device

Secondary Outcomes (1)

  • Frisbee Test - Device

    After each treatment on the AMES device.

Study Arms (1)

AMES Therapy and Diagnostic

EXPERIMENTAL

During treatment, the AMES device rotates the hand, into flexion and extension, while the patient assists with this motion,and while the lengthening muscle(s) are vibrated mechanically. At the end of the treatment, several diagnostic tests are performed to measure the participant's level of proprioceptive perception. This study provides for 25 AMES treatments and diagnostic tests over 8-13 weeks, at a rate of 2-3 sessions per week.

Device: AMES Therapy

Interventions

During the therapy session, the AMES device rotates the hand into flexion and extension, while the patient assists with this motion, as possible. At the same time, the AMES device provides sensory stimulation by vibrating the tendons of muscles stretched by the movement. The vibratory stimulus switches from one side of the limb to the other when the rotation reverses direction so that the sensory stimulation remains functionally related to the movement. The subject will receive visual bio-feedback of their contribution to the motor movement.

AMES Therapy and Diagnostic

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Traumatic incomplete SCI, stroke or acquired brain injured ABI subjects.
  • Able to tolerate sitting upright at for at least 1 hour.
  • Significant, but not complete, motor deficit in the hand and wrist, as determined by the Study Physician performing the screening.
  • Significant, but not complete somatosensory deficit in the hand and wrist as determined by the Study Physician performing the screening.
  • Cognitively and behaviorally capable of complying with the regimen.

You may not qualify if:

  • Fracture of the treated limb resulting in loss of range of motion.
  • Progressive neurodegenerative disorder.
  • DVT of the treated extremity.
  • Uncontrolled seizure disorder.
  • Uncontrolled high blood pressure/angina.
  • Osteo- or rheumatoid arthritis limiting range of motion
  • Contractures equal to or greater than 50% of the normal ROM.
  • Chronic ITB therapy.
  • Peripheral nerve injury of the treated extremity.
  • Pain in affected limb or exercise intolerance.
  • Participation in another therapy or activity-based program.
  • Skin condition not tolerant of device.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oregon Health and Science University

Portland, Oregon, 97239, United States

Location

Related Publications (3)

  • Cordo P, Lutsep H, Cordo L, Wright WG, Cacciatore T, Skoss R. Assisted movement with enhanced sensation (AMES): coupling motor and sensory to remediate motor deficits in chronic stroke patients. Neurorehabil Neural Repair. 2009 Jan;23(1):67-77. doi: 10.1177/1545968308317437. Epub 2008 Jul 21.

    PMID: 18645190BACKGROUND
  • Backus D, Cordo P, Gillott A, Kandilakis C, Mori M, Raslan AM. Assisted movement with proprioceptive stimulation reduces impairment and restores function in incomplete spinal cord injury. Arch Phys Med Rehabil. 2014 Aug;95(8):1447-53. doi: 10.1016/j.apmr.2014.03.011. Epub 2014 Mar 28.

    PMID: 24685386BACKGROUND
  • Cordo P, Wolf S, Lou JS, Bogey R, Stevenson M, Hayes J, Roth E. Treatment of severe hand impairment following stroke by combining assisted movement, muscle vibration, and biofeedback. J Neurol Phys Ther. 2013 Dec;37(4):194-203. doi: 10.1097/NPT.0000000000000023.

    PMID: 24232364BACKGROUND

MeSH Terms

Conditions

Spinal Cord InjuriesStrokeBrain Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesCerebrovascular DisordersBrain DiseasesVascular DiseasesCardiovascular DiseasesCraniocerebral Trauma

Results Point of Contact

Title
Paul Cordo
Organization
AMES Technology Inc.

Study Officials

  • Paul J Cordo, Ph.D

    Oregon Health and Science University

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Site Sub-Investigator

Study Record Dates

First Submitted

October 21, 2013

First Posted

November 1, 2013

Study Start

October 1, 2013

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

June 13, 2019

Results First Posted

June 13, 2019

Record last verified: 2019-06

Locations